210 related articles for article (PubMed ID: 24608986)
1. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.
Graf SA; Busch C; Bosserhoff AK; Besch R; Berking C
J Invest Dermatol; 2014 Aug; 134(8):2212-2220. PubMed ID: 24608986
[TBL] [Abstract][Full Text] [Related]
2. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
3. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
[TBL] [Abstract][Full Text] [Related]
4. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.
Lv XB; Wu W; Tang X; Wu Y; Zhu Y; Liu Y; Cui X; Chu J; Hu P; Li J; Guo Q; Cai Z; Wu J; Hu K; Ouyang N
Oncotarget; 2015 Nov; 6(34):36370-82. PubMed ID: 26461473
[TBL] [Abstract][Full Text] [Related]
6. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
8. SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.
Cronin JC; Watkins-Chow DE; Incao A; Hasskamp JH; Schönewolf N; Aoude LG; Hayward NK; Bastian BC; Dummer R; Loftus SK; Pavan WJ
Cancer Res; 2013 Sep; 73(18):5709-18. PubMed ID: 23913827
[TBL] [Abstract][Full Text] [Related]
9. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
10. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
[TBL] [Abstract][Full Text] [Related]
12. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
Bosserhoff AK; Echtenacher B; Hein R; Buettner R
Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
[TBL] [Abstract][Full Text] [Related]
13. SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter.
Hodonsky CJ; Kleinbrink EL; Charney KN; Prasad M; Bessling SL; Jones EA; Srinivasan R; Svaren J; McCallion AS; Antonellis A
Mol Cell Neurosci; 2012 Feb; 49(2):85-96. PubMed ID: 22037207
[TBL] [Abstract][Full Text] [Related]
14. PAX3 and SOX10 activate MET receptor expression in melanoma.
Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
[TBL] [Abstract][Full Text] [Related]
15. Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.
Seong I; Min HJ; Lee JH; Yeo CY; Kang DM; Oh ES; Hwang ES; Kim J
PLoS One; 2012; 7(2):e31477. PubMed ID: 22363655
[TBL] [Abstract][Full Text] [Related]
16. Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation.
Lee KE; Nam S; Cho EA; Seong I; Limb JK; Lee S; Kim J
BMC Genomics; 2008 Sep; 9():408. PubMed ID: 18786246
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
18. Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.
Bosserhoff AK
Pigment Cell Res; 2005 Dec; 18(6):411-6. PubMed ID: 16280006
[TBL] [Abstract][Full Text] [Related]
19. SOX10, in combination with Sp1, regulates the endothelin receptor type B gene in human melanocyte lineage cells.
Yokoyama S; Takeda K; Shibahara S
FEBS J; 2006 Apr; 273(8):1805-20. PubMed ID: 16623715
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro.
Callejo SA; Marshall JC; Cools-Lartigue J; Saraiva VS; Burnier MN
Melanoma Res; 2004 Apr; 14(2):91-5. PubMed ID: 15057037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
